The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies
Amelia Ruffatti, Marta Tonello, Maria Favarò, Teresa Del Ross, Antonia Calligaro, Alessandra Teresa Ruffatti, Maria Teresa Gervasi, Ariela Hoxha
Topics & Concepts
MedicineHydroxychloroquinePregnancyAntiphospholipid syndromeLive birthCochrane LibraryAdverse effectAspirinRefractory (planetary science)Retrospective cohort studyObstetricsInternal medicineMeta-analysisPediatricsThrombosisGeneticsPhysicsDiseaseCoronavirus disease 2019 (COVID-19)BiologyInfectious disease (medical specialty)AstrobiologySystemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsPregnancy and Medication Impact